Technical information
Manufacturer
THERATECHNOLOGIES INTERNATIONAL LIMITED
Presentation
TROGARZO 200 mg/1,33 mL (ibalizumab), solution pour perfusion
2 flacons de 1,33 mL (CIP : 34009 589 018 9 8)
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
jpSJWJn5SAa35P3n